Drug Type Small molecule drug |
Synonyms Compound 15(InSilico Medicine) |
Target |
Mechanism PHD2 inhibitors(egl-9 family hypoxia inducible factor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18N6O3 |
InChIKeyROTOKWNRJPNVEV-AWEZNQCLSA-N |
CAS Registry2924182-08-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia | Preclinical | CN | 08 Jan 2024 |